MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Maravai LifeSciences (MRVI) Stock: Buy, Sell, or Hold?
$7.86
-0.16 (-2.00%)
âŧ
5d:
+5.5%
30d:
+11.33%
90d:
+35.99%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
50/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$6.96 â $8.03
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-85.9x
Next 12M consensus est.
Wall Street Target
$9.42
+19.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.80 / $8.62
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MRVI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When MRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MRVI is currently trading at $7.86, which is considered slightly high relative to its 30-day fair value range of $6.96 to $8.03.
Technical Outlook: Technically, MRVI is in a uptrend. Immediate support is located at $6.80, while resistance sits at $8.62.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.42 (+19.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRVI is in a uptrend. Immediate support is located at $6.80, while resistance sits at $8.62.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.42 (+19.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$6.96 -
$8.03
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
Trading Range & Key Levels
30-Day Trading Range
$6.96 -
$8.03
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$6.80
Resistance Level
$8.62
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($9.42)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-85.90
Wall Street Target
$9.42
(+19.8%)
Revenue Growth (YoY)
10.1%
Earnings Growth (YoY)
-32.7%
Profit Margin
-30.8%
Share MRVI Analysis
Share this live MRVI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MRVI)
Bullish
4 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Aug 19, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is abuzz with positive sentiment towards $MRVI with no recent news articles available to provide context.
Key Retail Themes:
Bullish sentiment
Lack of news
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:18 AM ET
Data refreshes hourly during market hours. Next update: 10:18 AM
Data refreshes hourly during market hours. Next update: 10:18 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 37 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MRVI Research Pages
